InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Thursday, 01/14/2021 12:09:01 PM

Thursday, January 14, 2021 12:09:01 PM

Post# of 238
Buy all you can under $7.00

This can surge at a moments notice. Lots of updates from the company coming on all fronts oncology, green agriculture, green industrial.

billion dollar plus market cap in the making. only 220 million market cap.

double digit dollars are coming you can make book on that!

under the radar gem just getting noticed now.

35 million shares only half are owned by insiders and institutions like cathie wood of ARKG ETF Crispr gene editing plays backed by ARKG is where you want to be invested.

EVGN Subsidiaries:

Evogene group supports independent entities focusing on a defined commercial field with an exclusive license to use our unique solution for product development.

4.Lavie Bio

Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing

Evogene's work in the consortium is expected to include the broadening of its artificial intelligence capabilities that are expected to extend the range of its GENErator AI solution (part of Evogene's CPB platform). Evogene's GENErator AI solution already includes computational capabilities directing "which" edit should be made to achieve a specific trait; and the capabilities developed within the framework of the consortium aim to improve "how" these edits are made.

EVGN biz presentation:

Genome Stocks-Gene Editing.

$PACB 6.2 billion market cap
$BEAM 5.4 billion market cap
$CRSP 13 billion market cap
$EDIT 4.8 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.8 billion market cap
$BLUE 3.3 billion market cap
$BNGO 1.2 billion market cap
$EVGN 220 million market cap 35 million shares 45% owned by institutions & insiders

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News